Ziftomenib

72 interactions 4 explained in plain English

Also sold as: Komzifti

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Ketoconazole Topical Ivabradine Ofloxacin Otic Octreotide Injection Oxaliplatin Injection Hydroxychloroquine

1 Contraindicated 71 Major

All (72) Contraindicated (1) Major (71)

Major

Ziftomenib Granisetron Injection Granisol An increased risk of QT interval prolongation and torsade de pointes Details Ziftomenib Histrelin Implant Supprelin An increased risk of QT interval prolongation and torsade de pointes Details Ziftomenib Hydroxychloroquine Plaquenil An increased risk of QT interval prolongation and torsade de pointes Details Ziftomenib Inotuzumab Ozogamicin Injection Besponsa An increased risk of QT interval prolongation and torsade de pointes Details Ziftomenib Ivabradine Corlanor An increased risk of QT interval prolongation and torsade de pointes Details Ziftomenib Lansoprazole Prevacid Reduced ziftomenib exposure and reduced efficacy of ziftomenib Details Ziftomenib Lefamulin Xenleta Increased risk of QT interval prolongation, an increased ziftomenib exposure and an increased risk of ziftomenib-related adverse r... Details Ziftomenib Lenacapavir Injection Sunlenca Increased ziftomenib exposure and an increased risk of ziftomenib-related adverse reactions Details Ziftomenib Lenacapavir Oral Sunlenca Increased ziftomenib exposure and an increased risk of ziftomenib-related adverse reactions Details Ziftomenib Lenvatinib Lenvima An increased risk of QT interval prolongation and torsade de pointes Details Ziftomenib Letermovir Injection Prevymis Increased ziftomenib exposure and an increased risk of ziftomenib-related adverse reactions Details Ziftomenib Levofloxacin Levaquin An increased risk of QT interval prolongation and torsade de pointes Details Ziftomenib Levofloxacin Injection Levaquin An increased risk of QT interval prolongation and torsade de pointes Details Ziftomenib Mefloquine Lariam® An increased risk of QT interval prolongation and torsade de pointes Details Ziftomenib Metronidazole Flagyl An increased risk of QT interval prolongation and torsade de pointes Details Ziftomenib Metronidazole Injection Flagyl An increased risk of QT interval prolongation and torsade de pointes Details Ziftomenib Metronidazole Topical MetroCream® An increased risk of QT interval prolongation and torsade de pointes Details Ziftomenib Metronidazole Vaginal MetroGel® Vaginal An increased risk of QT interval prolongation and torsade de pointes Details Ziftomenib Mitapivat Aqvesme Reduced ziftomenib exposure and reduced efficacy of ziftomenib Details Ziftomenib Moxifloxacin Avelox An increased risk of QT interval prolongation and torsade de pointes Details Ziftomenib Moxifloxacin Injection Avelox An increased risk of QT interval prolongation and torsade de pointes Details Ziftomenib Moxifloxacin Ophthalmic Moxeza® An increased risk of QT interval prolongation and torsade de pointes Details Ziftomenib Nafarelin Nasal Spray Synarel An increased risk of QT interval prolongation and torsade de pointes Details Ziftomenib Nafcillin Injection Unipen® Injection Reduced ziftomenib exposure and reduced efficacy of ziftomenib Details Ziftomenib Nizatidine Axid® Reduced ziftomenib exposure and reduced efficacy of ziftomenib Details Ziftomenib Octreotide Bynfezia An increased risk of QT interval prolongation and torsade de pointes Details Ziftomenib Octreotide Injection Bynfezia An increased risk of QT interval prolongation and torsade de pointes Details Ziftomenib Ofloxacin Floxin® An increased risk of QT interval prolongation and torsade de pointes Details Ziftomenib Ofloxacin Ophthalmic Ocuflox An increased risk of QT interval prolongation and torsade de pointes Details Ziftomenib Ofloxacin Otic Floxin® Otic An increased risk of QT interval prolongation and torsade de pointes Details Ziftomenib Oxaliplatin Injection Eloxatin® An increased risk of QT interval prolongation and torsade de pointes Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.